Malaria: Clinical Trials

138 trials for Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

138 completed. 138 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4138Completed 138

Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria

Trials (filtered) newest first · largest first

All 138 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vivax Elimination With Tafenoquine (VET) Study
Tafenoquine - Malaria, Malaria, Vivax
Phase 4CompletedShoklo Malaria Research Unit12422025-02-192026-01-06
Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi
Dihydroartemisinin-Piperaquine, Chloroquine, Sulfadoxine-pyrimethamine-amodiaquine - Malaria,Falciparum, Anemia in Children
Phase 4CompletedLiverpool School of Tropical Medicine7882024-10-142026-07-30
The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy
Artemether-lumefantrine, Dihydroartemisinin-Piperaquine - Falciparum; Malaria
Phase 4CompletedInfectious Diseases Research Collaboration, Uganda1602024-05-282026-07-06
Private Medicine Retailer-based Trial of Malaria Tests and Conditional Treatment Subsidies Among Patients With Fever
Provide the diagnostic (RDT) for free to clients suspected of having malaria and provide a subsidized ACT to only those testing positive - Malaria Falciparum
Phase 4CompletedClinton Health Access Initiative Inc.202023-12-312025-04-15
Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria
Artesunate - Plasmodium Falciparum Infection
Phase 4CompletedNational Institute of Allergy and Infectious Diseases (NIAID)902023-11-292026-06-18
Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo
Artesunate-amodiaquine, Artemether-lumefantrine - Uncomplicated Plasmodium Falciparum Malaria
Phase 4CompletedMinistry of Public Health, Democratic Republic of the Congo12602023-05-012024-11-05
Comparing Chemoprevention Drugs for School-based Malaria Control
Dihydroartemisinin-Piperaquine, Chloroquine, Sulfadoxine pyrimethamine - Malaria,Falciparum, Anemia in Children
Phase 4CompletedUniversity of Maryland, Baltimore6462023-02-132023-08-07
Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax
Chloroquine, Primaquine - Efficacy, Malaria
Phase 4CompletedDinka Dugassa1002022-12-192023-09-22
Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia
Amodiaquine-artesunate (ASAQ), Artemether+Lumefantrine (AL) - Plasmodium Falciparum, Malaria
Phase 4CompletedCenters for Disease Control and Prevention3522022-08-092024-05-07
In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique
AL (Coartem), AS-AQ (Carsucam), DHP - Malaria
Phase 4CompletedCentro de Investigacao em Saude de Manhica8702022-03-162025-08-27
Comparing Chemoprevention Approaches for School-based Malaria Control
Dihydroartemisinin-Piperaquine, Chloroquine - Malaria,Falciparum, Anemia in Children
Phase 4CompletedUniversity of Maryland, Baltimore7462022-02-012022-11-15
Short Course Radical Cure of P. Vivax Malaria in Nepal
primaquine - Malaria, Malaria, Vivax
Phase 4CompletedMenzies School of Health Research272021-10-272024-08-29
Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommates
Amodiaquine Sulfadoxine-Pyrimethamin administration, Dihydroartemisinin-Piperaquine, Standard HRP2-RDT - Malaria, Malaria Prophylaxis
Phase 4CompletedInstitut de Recherche en Sciences de la Sante, Burkina Faso5262021-07-072025-01-22
Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure
Primaquine, Artesunate - Vivax Malaria
Phase 4CompletedUniversity of Maryland, Baltimore1602021-04-152026-06-03
Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy
Dihydroartemisinin-piperaquine - Drug-Drug Interaction, HIV Infection
Phase 4CompletedUniversity of California, San Francisco1942020-11-232025-03-14
Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo
Artesunate-amodiaquine, Artemether-lumefantrine - Malaria
Phase 4CompletedMinistry of Public Health, Democratic Republic of the Congo11172020-10-262022-02-09
Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites
Artemether-lumefantrine - MALARIA
Phase 4CompletedProgramme National de Lutte contre le Paludisme, Niger2592020-09-012021-10-07
Gut and Azithromycin Mechanisms in Infants and Children II
Azithromycin, Placebo - Malaria
Phase 4CompletedUniversity of California, San Francisco4492020-08-212023-06-29
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania
Dihydroartemisinin-Piperaquine (DP) - Malaria
Phase 4CompletedNational Institute for Medical Research, Tanzania41002020-07-202024-11-20
Malaria High-Risk Populations in Namibia
Presumptive treatment with Artemether-lumefantrine (AL), Enhanced vector control - Malaria
Phase 4CompletedUniversity of California, San Francisco33022019-10-312020-11-03

Showing 20 of 138. Sign in to see all of them.

Narrower conditions

Malaria, Falciparum (45)  ·  Malaria, Vivax (12)  ·  Anemia (6)  ·  Disease (6)  ·  HIV Infections (5)  ·  Pneumonia (4)  ·  Acquired Immunodeficiency Syndrome (3)  ·  Diarrhea (3)  ·  Fever (3)  ·  Bacterial Infections (2)  ·  Birth Weight (2)  ·  Asthma (1)  ·  Chlamydia Infections (1)  ·  Escherichia coli Infections (1)

Broader conditions

Mosquito-Borne Diseases (138)  ·  Parasitic Diseases (138)  ·  Protozoan Infections (138)  ·  Vector Borne Diseases (138)  ·  Infections (137)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Communicable Diseases (8)  ·  Genital Diseases (8)  ·  Immune System Diseases (8)  ·  Pathologic Processes (8)  ·  Sexually Transmitted Diseases (8)  ·  Signs and Symptoms (8)  ·  Urogenital Diseases (8)  ·  Blood-Borne Infections (7)

Interventions

Artemether, Lumefantrine Drug Combination (50)  ·  Primaquine (19)  ·  Chloroquine (18)  ·  amodiaquine, artesunate drug combination (15)  ·  Artesunate (13)  ·  fanasil, pyrimethamine drug combination (13)  ·  Amodiaquine (11)  ·  Rapid Diagnostic Tests (6)  ·  Mefloquine (5)  ·  Quinine (4)  ·  Sulfadoxine (4)  ·  atovaquone, proguanil drug combination (4)  ·  Artemether (3)  ·  Azithromycin (3)  ·  Lumefantrine (3)

Sponsors

London School of Hygiene and Tropical Medicine (13)  ·  Centers for Disease Control and Prevention (11)  ·  Bandim Health Project (6)  ·  University of California, San Francisco (6)  ·  Sanofi (5)  ·  Menzies School of Health Research (4)  ·  University of Oxford (4)  ·  Albert Schweitzer Hospital (3)  ·  Centre Muraz (3)  ·  Centro de Investigacao em Saude de Manhica (3)  ·  Karolinska University Hospital (3)  ·  Ministry of Public Health, Democratic Republic of the Congo (3)  ·  Muhimbili University of Health and Allied Sciences (3)  ·  Professor Anders Björkman (3)  ·  Universitas Indonesia (3)

Countries

Tanzania (18)  ·  Burkina Faso (11)  ·  Kenya (11)  ·  Ghana (10)  ·  Malawi (9)  ·  Uganda (8)  ·  Democratic Republic of the Congo (6)  ·  Guinea-Bissau (6)  ·  Ethiopia (5)  ·  Indonesia (5)  ·  Afghanistan (4)  ·  Cambodia (4)  ·  Cameroon (4)  ·  Gabon (4)  ·  Senegal (4)

Top investigators

Andreas Martensson, PhD (3)  ·  Harry Tagbor, DrPH (3)  ·  Salim Abdulla, MD, PhD (3)  ·  Andreas Martensson (2)  ·  Christopher Whitty, FRCP (2)  ·  Dysoley Lek, MD (2)  ·  Gauthier Mesia Kahunu, PhD (2)  ·  Halidou Tinto, PharmD, PhD (2)  ·  Lauren Cohee, MD MS (2)  ·  Michel A. Missinou, PhD (2)  ·  Mwinyi I Msellem (2)  ·  Peter Aaby (2)  ·  Rachel N Bronzan, MD, MPH (2)  ·  Sarah G Staedke, MD, PhD (2)

Results publications

PMID 25421474, PMID 18828899, PMID 30860013, PMID 39324693, PMID 11103309, PMID 16163624, PMID 17093247, PMID 17259188, PMID 17467344, PMID 17550470, PMID 18008241, PMID 18008242, PMID 18067679, PMID 18503714, PMID 18575626, PMID 18831691, PMID 18831737, PMID 19102746, PMID 19127975, PMID 19399156, PMID 19848610, PMID 20207689, PMID 20299957, PMID 20932805, PMID 2096501, PMID 21148503, PMID 21304921, PMID 21410954, PMID 21838909, PMID 21947399, PMID 22185672, PMID 22514617, PMID 22531245, PMID 22554092, PMID 23175563, PMID 23212366, PMID 23617626, PMID 24079295, PMID 24079992, PMID 24215306, PMID 24678612, PMID 24948695, PMID 25075834, PMID 25224002, PMID 25428714, PMID 25436614, PMID 25739769, PMID 25858004, PMID 26016871, PMID 26258474

NIH funding

R01HD068174 (2), 5UM1AI148689-03 (1), R01AI103228 (1), R01HL134211 (1)